Sandbox fungal meningitis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 120: | Line 120: | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Induction Phrase(for 2 wks)'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Induction Phrase(for 2 wks)'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Amphotericin B deoxycholate]] 0.7 mg/kg/day''''' | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[ | |||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS'' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[5- | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[5-Fluorocytosine]] 100 mg/kg/day OR''''' | ||
|- | |||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Consolidation phase(for 8 wks)'' | |||
|- | |||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 400 mg/day'''''<BR>''OR''<BR>▸ '''''[[Itraconazole]] 400 mg/day''''' | |||
|-! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Maintenance phase'' | |||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Fluconazole]] 200 mg/day OR''''' | |||
|- | |- | ||
|} | |||
|} | |||
</div></div> |
Revision as of 00:42, 19 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Sheng Shi, M.D. [2]
fungal meningitis
Blastomyces
|
Candidiasis
|
Histoplasma
|
Coccidioides
|
Cryptococcus, HIV/AIDS
|